Abstract
Endoplasmic reticulum (ER) stress induced by free fatty acids (FFA) is important to β-cell loss during the development of type 2 diabetes. To test whether vanadium compounds could influence ER stress and the responses in their mechanism of antidiabetic effects, we investigated the effects and the mechanism of vanadyl bisacetylacetonate [VO(acac)2] on β cells upon treatment with palmitate, a typical saturated FFA. The experimental results showed that VO(acac)2 could enhance FFA-induced signaling pathways of unfolded protein responses by upregulating the prosurvival chaperone immunoglobulin heavy-chain binding protein/78-kDa glucose-regulated protein and downregulating the expression of apoptotic C/EBP homologous protein, and consequently the reduction of insulin synthesis. VO(acac)2 also ameliorated FFA-disturbed Ca2+ homeostasis in β cells. Overall, VO(acac)2 enhanced stress adaption, thus protecting β cells from palmitate-induced apoptosis. This study provides some new insights into the mechanisms of antidiabetic vanadium compounds.
Similar content being viewed by others
Abbreviations
- acac:
-
Acetylacetone
- BiP/GRP78:
-
Immunoglobulin heavy-chain binding protein/78-kDa glucose-regulated protein
- BSA:
-
Bovine serum albumin
- cDNA:
-
Complementary DNA
- CHOP:
-
C/EBP homologous protein
- DCFH-DA:
-
2′,7′-Dichlorofluorescein diacetate
- ER:
-
Endoplasmic reticulum
- FBS:
-
Fetal bovine serum
- FFA:
-
Free fatty acid
- Fluo-3 AM:
-
1-[2-Amino-5-(2,7-dichloro-6-hydroxy-3-oxo-9-xanthenyl)phenoxy]-2-(2-amino-5-methylphenoxy)ethane-N,N,N′,N′-tetraacetic acid, pentaacetoxymethyl ester
- HBSS:
-
N-(2-Hydroxyethyl)piperazine-N′-ethanesulfonic acid balanced salt solution
- HEPES:
-
N-(2-Hydroxyethyl)piperazine-N′-ethanesulfonic acid
- IRE1α:
-
Inositol-requiring enzyme 1α
- mRNA:
-
Messenger RNA
- MTT:
-
3-(4,5-Dimethylthiazoyl-2-yl)-2,5-diphenyltetrazolium bromide
- PBS:
-
Phosphate-buffered saline
- PERK:
-
Protein kinase regulated by RNA-like endoplasmic-reticulum-associated kinase
- PI:
-
Propidium iodide
- ROS:
-
Reactive oxygen species
- TBS:
-
20 mM tris(hydroxymethyl)aminomethane–HCl, 1.37 mM NaCl, pH 7.6
- TBST:
-
20 mM tris(hydroxymethyl)aminomethane–HCl, 1.37 mM NaCl, pH 7 containing 0.1% Tween 20
- Tris:
-
Tris(hydroxymethyl)aminomethane
- UPR:
-
Unfolded protein response
- VO(acac)2 :
-
Vanadyl bisacetylacetonate
- Xbp-1:
-
X-box binding protein 1
References
Poucheret P, Verma S, Grynpas MD, McNeill JH (1998) Mol Cell Biochem 188:73–80
Thompson KH, Orvig C (2006) J Inorg Biochem 100:1925–1935
Thompson KH, Lichter J, Lebel C, Scaife MC, McNeill JH, Orvig C (2009) J Inorg Biochem 103:554–558
Thompson KH (1999) Biofactors 10:43–51
Sakurai H, Yoshikawa Y, Yasui H (2008) Chem Soc Rev 37:2383–2392
Hiromura M, Adachi Y, Machida M, Hattori M, Sakurai H (2009) Metallomics 1:92–100
Sakurai H, Katoh A, Kiss T, Jakusch T, Hattori M (2010) Metallomics 2:670–682
Margina D, Velescu B, Uivarosi V, Aldea V, Negres S, Mitrea N (2010) Febs J 277:61
Bolkent S, Bolkent S, Yanardag R, Tunali S (2005) Diabetes Res Clin Pract 70:103–109
Cam MC, Li WM, McNeill JH (1997) Metabolism 46:769–778
Shukla R, Padhye S, Modak M, Ghaskadbi SS, Bhonde RR (2007) Rev Diabet Stud 4:33–43
Saeki M, Maeda S, Kamisaki Y (2002) J Cell Biochem 85:721–727
Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD (1988) Diabetes 37:1020–1024
McGarry JD, Dobbins RL (1999) Diabetologia 42:128–138
Shimabukuro M, Zhou YT, Levi M, Unger RH (1998) Proc Natl Acad Sci USA 95:2498–2502
Cnop M, Welsh N, Jonas J-C, Jörns A, Lenzen S, Eizirik DL (2005) Diabetes 54:S97–S107
Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Diabetes 52:102–110
Ahren B (2005) Curr Mol Med 5:275–286
Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL (2004) Endocrinology 145:5087–5096
Karaskov E, Scott C, Zhang L, Teodoro T, Ravazzola M, Volchuk A (2006) Endocrinology 147:3398–3407
Wang H, Kouri G, Wollheim CB (2005) J Cell Sci 118:3905–3915
Schroder M, Kaufman RJ (2005) Mutat Res 569:29–63
Boyce M, Yuan J (2006) Cell Death Differ 13:363–373
Cnop M, Ladriere L, Hekerman P, Ortis F, Cardozo AK, Dogusan Z, Flamez D, Boyce M, Yuan J, Eizirik DL (2007) J Biol Chem 282:3989–3997
Song B, Scheuner D, Ron D, Pennathur S, Kaufman RJ (2008) J Clin Invest 118:3378–3389
Cunha DA, Hekerman P, Ladriere L, Bazarra-Castro A, Ortis F, Wakeham MC, Moore F, Rasschaert J, Cardozo AK, Bellomo E, Overbergh L, Mathieu C, Lupi R, Hai T, Herchuelz A, Marchetti P, Rutter GA, Eizirik DL, Cnop M (2008) J Cell Sci 121:2308–2318
Choi E, Kim HE, Shin HC, Jang HJ, Lee KW, Kim YS, Kang SS, Chun JS, Kang Y (2007) Mol Cell Endocrinol 272:50–62
Lipson KL, Ghosh R, Urano F (2008) PLoS One 3:e1648
Yang XG, Yang XD, Yuan L, Wang K, Crans DC (2004) Pharm Res 21:1026–1033
Reul BA, Amin SS, Buchet JP, Ongemba LN, Crans DC, Brichard SM (1999) Br J Pharmacol 126:467–477
Zhang SQ, Zhong XY, Lu WL, Zheng L, Zhang X, Sun F, Fu GY, Zhang Q (2005) J Inorg Biochem 99:1064–1075
Amin SS, Cryer K, Zhang B, Dutta SK, Eaton SS, Anderson OP, Miller SM, Reul BA, Brichard SM, Crans DC (2000) Inorg Chem 39:406–416
Garribba E, Micera G, Sanna D (2006) Inorg Chim Acta 359:4470–4476
Crans DC, Zhang B, Gaidamauskas E, Keramidas AD, Willsky GR, Roberts CR (2010) Inorg Chem 49:4245–4256
Sanna D, Buglyo P, Micera G, Garribba E (2010) J Biol Inorg Chem 15:825–839
Valko M, Morris H, Cronin MTD (2005) Curr Med Chem 12:1161–1208
Zhao YB, Ye LH, Liu HX, Xia Q, Zhang Y, Yang XD, Wang K (2010) J Inorg Biochem 104:371–378
Laybutt DR, Preston AM, Akerfeldt MC, Kench JG, Busch AK, Biankin AV, Biden TJ (2007) Diabetologia 50:752–763
Gething MJ (1999) Semin Cell Dev Biol 10:465–472
Suzuki T, Lu J, Zahed M, Kita K, Suzuki N (2007) Arch Biochem Biophys 468:1–14
Fonseca SG, Burcin M, Gromada J, Urano F (2009) Curr Opin Pharmacol 9:763–770
Kennedy BP (1999) Biomed Pharmacother 53:466–470
Sambrook JF (1990) Cell 61:197–199
Hosoi T, Saito A, Kume A, Okuma Y, Nomura Y, Ozawa K (2008) Eur J Pharmacol 594:44–48
Goc A (2006) Cent Eur J Biol 1:314–332
Kim K-A, Lee M-S (2010) J Diabetes Invest 1:232–238
Acknowledgments
This project (no. 20971008) was supported by the NSFC and the Research Fund for the Doctoral Program of Higher Education of China. We thank John J. Hefferren of the University of Kansas for editing the manuscript.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gao, Z., Zhang, C., Yu, S. et al. Vanadyl bisacetylacetonate protects β cells from palmitate-induced cell death through the unfolded protein response pathway. J Biol Inorg Chem 16, 789–798 (2011). https://doi.org/10.1007/s00775-011-0780-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-011-0780-0